Key statistics
As of last trade, Xenon Pharmaceuticals Inc (XENE:NMQ) traded at 31.59, 18.12% above the 52 week low of 26.74 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 32.79 |
---|---|
High | 32.79 |
Low | 31.47 |
Bid | 31.57 |
Offer | 31.60 |
Previous close | 32.60 |
Average volume | 907.10k |
---|---|
Shares outstanding | 76.73m |
Free float | 75.43m |
P/E (TTM) | -- |
Market cap | 2.50bn USD |
EPS (TTM) | -3.22 USD |
Data delayed at least 15 minutes, as of Jul 15 2025 20:24 BST.
More ▼
- Xenon Joins the Russell 3000® and Russell 2000® Indexes
- Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Xenon Announces Appointment of Darren Cline as Chief Commercial Officer
- Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
- Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference
- Xenon Reports First Quarter 2025 Financial Results and Provides Business Update
- Xenon to Report Q1 2025 Financial Results on May 12, 2025
- Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025
More ▼